Diana Rigueur email: [email protected] phone: 310-794-9489 office: 312 Hershey Hall Research Interests Selected Publications Dr
To keep these risks low and ensure the medication does its job, its crucial to follow the prescribed schedule exactly
This isnt just about recovering from major injuries, but also about the biology of muscle repair and maintenance when physically active. A candidate drug already in clinical trials An experimental PGDHi compound, MF-300, has already completed Phase 1 clinical trials and been found safe in humans, with Phase 2b trials for age-related muscle loss (called sarcopenia) planned later this year
1 2 3 4 5 6 7 8 9 10 11 12 "NCAA Banned Substances"
Miracco C, Margherita De Santi M, Schurfeld K, Santopietro R, Lalinga AV, Fimiani M et al
Chasing a substance no one was even sure existed